13. 多発性硬化症/視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


臨床試験数 : 3,340 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05758831
(ClinicalTrials.gov)
February 28, 202317/2/2023RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.A Prospective Randomized Trial of Non-inferiority Comparing RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple SclerosisMultiple Sclerosis;Relapsing-remitting Multiple SclerosisDrug: Perfusion of treatment Rituximab;Drug: Perfusion of treatment OcrelizumabRennes University HospitalNULLNot yet recruiting18 Years55 YearsAll386Phase 3France